TERUMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,663 JPY | +0.15% |
|
+2.01% | +15.23% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 905B 5.89B | Sales 2025 * | 971B 6.32B | Capitalization | 3,954B 25.71B |
|---|---|---|---|---|---|
| Net income 2024 * | 108B 704M | Net income 2025 * | 125B 814M | EV / Sales 2024 * | 4.39 x |
| Net Debt 2024 * | 23.33B 152M | Net cash position 2025 * | 55.65B 362M | EV / Sales 2025 * | 4.01 x |
| P/E ratio 2024 * |
36.7
x | P/E ratio 2025 * |
31.7
x | Employees | 30,207 |
| Yield 2024 * |
0.82% | Yield 2025 * |
0.9% | Free-Float | 95.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Terumo Corporation
More recommendations
More press releases
More news
| 1 day | +0.15% | ||
| 1 week | +2.01% | ||
| Current month | -1.13% | ||
| 1 month | +0.19% | ||
| 3 months | +5.07% | ||
| 6 months | +26.57% | ||
| Current year | +15.23% |
1 week
2 613.00
2 729.50
1 month
2 513.002 729.50
Current year
2 267.003 014.50
1 year
1 856.003 014.50
3 years
1 708.003 014.50
5 years
1 440.003 014.50
10 years
488.503 014.50
| Managers | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 66 | 81-03-31 |
Naoki Muto
DFI | Director of Finance/CFO | - | - |
Kazuhisa Senshu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shouji Hatano
CMP | Compliance Officer | 64 | 83-03-31 |
Hidenori Nishi
BRD | Director/Board Member | 73 | 20-06-24 |
Shinjiro Sato
BRD | Director/Board Member | 63 | 04-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 31 M€ | +13.91% | ||
| 1.94% | 31,732 M€ | +15.18% | - | |
| 1.93% | 1,198 M€ | +14.37% | - | |
| 1.90% | 16,729 M€ | +14.33% | - | |
| 1.82% | 67,864 M€ | +15.20% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 2,663 | +0.15% | 1,700,800 |
| 24-05-01 | 2,659 | -1.28% | 2,634,100 |
| 24-04-30 | 2,694 | +3.18% | 3,760,300 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,663
JPY
Average target price
2,951
JPY
Spread / Average Target
+10.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.23% | 25.86B | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.82B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| -0.03% | 25.03B |
- Stock Market
- Equities
- 4543 Stock